Lara Dorigo

Lara is a passionate IP litigator and licensing specialist. She has extensive experience with pharmaceutical and biologics patent litigation before courts and arbitral tribunals, including disputes regarding small molecules, monoclonal antibodies, biosimilars, immunotherapies, diagnostics and SPCs. Lara also handles cases in the fields of medtech, chemistry and mechanics and she equally enjoys acting in trademark, copyright and unfair competition litigation.

In addition, Lara advises clients on branding strategies, parallel import and grey market issues, selective distribution agreements and entertainment law. She provides transactional and legal support to her clients on licensing, R&D agreements, and other sorts of technology transfer agreements and issues, and she advises on life sciences regulatory matters.

Lara is also a non-permanent judge of the Federal Patent Court. She is the author of many publications and a frequent speaker on IP and licensing topics.

Her studies at New York University School of Law and the experience gained working in the IP litigation group of a magic circle firm in London complement Lara's knowledge of Swiss intellectual property law and procedure.

Lara's expertise was recognized by Chambers Europe, The Legal 500, IAM Patent 1000, WTR 1000, Who's Who Legal ('Global Leader IP-Patents', Thought Leader Patents/Trademarks/Life Sciences), Best Lawyers, WIPR Leaders, Managing Intellectual Property ('IP Star'), Expert Guides and LMG Life Sciences. WIPR lists her as one of the World's Influential Women in IP and she appears in Managing Intellectual Property's Top 250 Women in IP.